Droogleever Fortuyn, H.A.

patient escitalopram treatment study depression placebo hepatitis c hepatitis therapy score group depressive side-effects effect baseline randomised trial scale bene ficial effect aliment pharmacol history feeling outcome genotype ribavirin anxiety prophylactic symptom pharmacol 24 weeks escitalopram group signi netherland publishing point aliment 1306–1317 concentration follow-up placebo group episode study code blackwell disorder rating tension development department anxiety scale sadness prophylactic treatment peg-ifn depressive episodes ficant depressive syndrome psychiatry center response incidence ficial radboud university nijmegen table increase beck depression inventory measure interferon peginterferon benzodiazepines rotterdam antidepressant analysis scl -90 medication characteristic study medication knegt sum scores 11 patients ef ficacy occurrence